Lifeboat Foundation

We specialize in the cryo-preservation of humans and pets, DNA & tissue storage as well as cryonics outreach and public education.

Testing blood levels of a protein that brain cells leak when faulty or dying detected people with Alzheimer’s disease years before their symptoms emerged.

‘It’s sort of this beautiful synergy between the human and the machine’

History Made

In a scientific first, Columbia neuroengineers have created a system that translates thought into intelligible, recognizable speech. By monitoring someone’s brain activity, the technology can reconstruct the words a person hears with unprecedented clarity. This breakthrough, which harnesses the power of speech synthesizers and artificial intelligence, could lead to new ways for computers to communicate directly with the brain. It also lays the groundwork for helping people who cannot speak, such as those living with as amyotrophic lateral sclerosis (ALS) or recovering from stroke, regain their ability to communicate with the outside world.

A new study led by the NASA Jet Propulsion Laboratory finds that 21 percent more storms will form for every 1.8° F (1° C) that ocean surface temperatures rise. See the projections based on currently accepted climate models: https://go.nasa.gov/2GcAS65

Bug and vulnerability hunting is a big business and the need for it is getting larger and larger. Up until this point, the majority of work had been from people. Either as hackers discovered holes and released exploits or as companies paid people to do the testing.

The machine triumphed in DARPA’s Cyber Grand Challenge, where teams automated white-hat hacking.

Early November 2018, Conrad Holton visited Japan at the invitation of Hamamatsu Photonics to attend the three-day Photon Fair, the company’s big event looking at its technologies and vision for the future. The Fair is held every five years near its headquarters in Hamamatsu City, about 150 miles southwest of Tokyo. In addition to thousands of customers, suppliers, and students who attended, the event was open to the public for one day to show the many technologies just emerging from the company’s research labs and how these technologies might impact fields ranging from the life sciences to transportation and manufacturing.

An interview with the CEO of Hamamatsu Photonics shows how an engineering company with a singular focus on photonics can succeed.

UNITY Biotechnologies has recently announced an expansion of its first-stage human trial of UBX0101, a drug that has been shown to have senolytic properties in mice [1] and that the company hopes will be useful in treating painful osteoarthritis of the knee.

An expanded clinical trial

UNITY Biotechnologies, a $495 million biotech company in the process of creating senolytic medicines that target one of the aging processes, has just announced an expansion of its first-stage human trial of the first drug in its pipeline (UBX0101), which targets painful osteoarthritis of the knee.

A participation in the annual Supercomputing conference taking place in Salt Lake City, UT, USA from November 14–17, 2016.